Moreover, galuteolin treatment could upregulate HO-1 expression and suppress the Iκκβ/NF-κB signaling pathway in RA-FLS cells, which suggested the potential of Gal as a treatment for RA. The gene discussed is GAL; the disease is rheumatoid arthritis.